This paper reviews the problems with the usual double-blind, placebo-controlled trials on which drug approvals are based, and advocates for a stricter form of testing psychiatric drugs with patient-relevant outcomes, real comparators, long-term outcomes, and assessment of harms.
A new meta-analysis analyzes randomized control trials of Mindfulness-Based Interventions for adolescents.
A randomized control trial finds that receiving peer support from individuals with similar lived experiences reduces one’s risk of readmission to an acute crisis unit.
Dr. Johnathan Shedler recently published a paper critiquing how the term “evidence-based” is being used in the field of psychotherapy.
A new randomized, double-blind, placebo-controlled trial has found bright light therapy to be a powerful intervention that could provide an alternative to medication for people with “bipolar depression.”
A recent RCT showed that vitamin B6 is as effective as propranolol for the treatment of akathisia.
New meta-analysis of smartphone based interventions demonstrates small-to-moderate effect.
Sheila Kaplan for the Boston Globe reports that Dr. Robert Califf, the Obama administration's nominee to lead the Food and Drug Administration (FDA), has removed his name from a series of scientific papers that he recently coauthored. The decision to remove his name, against publication ethics standards, has brought Califf under renewed criticism.